LEIDS UNI MEDISCH CT has a total of 16 patent applications. Its first patent ever was published in 1999. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and computer technology are EYESERV GMBH, GRUPO IND PECUARIO S A DE C V and GLEAVE MARTIN.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 1 | |
#5 | Netherlands | 1 | |
#6 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Computer technology | |
#4 | Control | |
#5 | Agriculture |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Healthcare informatics | |
#6 | Teaching materials | |
#7 | Animal care |
# | Name | Total Patents |
---|---|---|
#1 | Rea Delphine Gabrielle Josette | 5 |
#2 | Melief Cornelis Johannes Maria | 5 |
#3 | Offringa Rienk | 5 |
#4 | Rademaker Hendrik Jan | 3 |
#5 | Hoeben Robert Cornelis | 3 |
#6 | Fallaux Frits Jacobus | 3 |
#7 | Van Der Vliet Pieter Charles | 2 |
#8 | De Jong Robert Niels | 2 |
#9 | Falkenburg Johan Herman Freder | 2 |
#10 | Nibbering Peter Hendricus | 1 |
Publication | Filing date | Title |
---|---|---|
WO2007055578A1 | Cyclic antimicrobial peptides derived from lactoferrin | |
EP1288292A1 | Long peptides of 22-40 amino acid residues that induce and/or enhance antigen specific immune responses. | |
NL1017747C1 | Simulator for working environment of anaesthetist, has expert system forming interface between medical model and medical data input unit | |
EP1213299A1 | Immunogenic epitopes of human papilloma virus and uses thereof | |
EP1191097A1 | Induction of exon skipping in eukaryotic cells | |
US7560105B1 | Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses | |
EP1104813A1 | Conditional replication of recombinant human adenovirus DNA carrying modified inverted terminal repeat sequences | |
EP1103265A1 | T-cells specific for polymorphic proteins on malignant cells |